State Treasurer State Of Michigan Has Trimmed Its Salesforce Com (CRM) Stake by $612,000; As Abiomed (ABMD) Shares Rose, Shareholder Essex Woodlands Health Ventures Has Lowered Its Position by $56.10 Million

May 22, 2018 - By Stephen Andrade

ABIOMED, Inc. (NASDAQ:ABMD) Logo

Essex Woodlands Health Ventures Inc decreased its stake in Abiomed Inc (ABMD) by 31.69% based on its latest 2017Q4 regulatory filing with the SEC. Essex Woodlands Health Ventures Inc sold 300,000 shares as the company’s stock rose 49.46% while stock markets declined. The hedge fund held 646,818 shares of the health care company at the end of 2017Q4, valued at $121.22M, down from 946,818 at the end of the previous reported quarter. Essex Woodlands Health Ventures Inc who had been investing in Abiomed Inc for a number of months, seems to be less bullish one the $17.14B market cap company. The stock increased 1.89% or $7.18 during the last trading session, reaching $386.35. About 439,568 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 128.67% since May 22, 2017 and is uptrending. It has outperformed by 117.12% the S&P500.

State Treasurer State Of Michigan decreased its stake in Salesforce Com Inc (CRM) by 2.9% based on its latest 2017Q4 regulatory filing with the SEC. State Treasurer State Of Michigan sold 6,000 shares as the company’s stock rose 10.89% while stock markets declined. The institutional investor held 201,156 shares of the prepackaged software company at the end of 2017Q4, valued at $20.56 million, down from 207,156 at the end of the previous reported quarter. State Treasurer State Of Michigan who had been investing in Salesforce Com Inc for a number of months, seems to be less bullish one the $93.19 billion market cap company. The stock decreased 0.74% or $0.93 during the last trading session, reaching $125.44. About 2.78M shares traded. salesforce.com, inc. (NYSE:CRM) has risen 39.46% since May 22, 2017 and is uptrending. It has outperformed by 27.91% the S&P500.

Investors sentiment decreased to 1.18 in Q4 2017. Its down 0.12, from 1.3 in 2017Q3. It is negative, as 19 investors sold ABMD shares while 110 reduced holdings. 55 funds opened positions while 97 raised stakes. 36.44 million shares or 5.39% less from 38.51 million shares in 2017Q3 were reported. Congress Asset Mgmt Ma invested 0.16% in ABIOMED, Inc. (NASDAQ:ABMD). Winfield Assocs Inc reported 5 shares. Balyasny Asset Mgmt Limited Liability Corp holds 0.01% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 23,812 shares. Glenmede Communications Na holds 0% or 2,781 shares. Yhb Invest Advsr Inc accumulated 9,466 shares. Stratos Wealth Ptnrs Ltd stated it has 0.01% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Point72 Asia (Hong Kong) invested in 51 shares or 0.01% of the stock. Gp holds 87,006 shares. Driehaus Capital Mgmt Ltd Liability Corp stated it has 0.04% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Huntington National Bank has 300 shares for 0% of their portfolio. Alliancebernstein LP holds 0.01% in ABIOMED, Inc. (NASDAQ:ABMD) or 58,762 shares. Schwab Charles Mngmt Inc accumulated 137,552 shares or 0.02% of the stock. Portolan Capital Mgmt Ltd Liability Corp invested 0.46% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Mason Street Advisors Ltd accumulated 20,695 shares. Price Cap Management Inc holds 8,444 shares or 0.55% of its portfolio.

Among 15 analysts covering Abiomed (NASDAQ:ABMD), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Abiomed had 36 analyst reports since August 4, 2015 according to SRatingsIntel. The company was maintained on Tuesday, May 1 by Morgan Stanley. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Monday, April 9 by Stephens. The firm earned “Buy” rating on Tuesday, August 9 by Jefferies. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Outperform” rating given on Friday, October 30 by Raymond James. The firm has “Overweight” rating by PiperJaffray given on Thursday, April 6. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Neutral” rating by BTIG Research on Monday, October 16. Piper Jaffray maintained the shares of ABMD in report on Thursday, February 1 with “Buy” rating. The stock has “Buy” rating by Jefferies on Tuesday, June 6. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Sterne Agee CRT on Tuesday, August 18. Jefferies maintained ABIOMED, Inc. (NASDAQ:ABMD) rating on Thursday, June 29. Jefferies has “Buy” rating and $16500 target.

Analysts await ABIOMED, Inc. (NASDAQ:ABMD) to report earnings on July, 26. They expect $0.80 EPS, up 77.78% or $0.35 from last year’s $0.45 per share. ABMD’s profit will be $35.50M for 120.73 P/E if the $0.80 EPS becomes a reality. After $0.80 actual EPS reported by ABIOMED, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since February 20, 2018, it had 0 insider buys, and 5 insider sales for $31.65 million activity. Greenfield Andrew J also sold $5.41 million worth of ABIOMED, Inc. (NASDAQ:ABMD) shares. BOLT WILLIAM J had sold 22,790 shares worth $7.93M. Shares for $6.09 million were sold by Howley Michael G. SUTTER MARTIN P sold 21,890 shares worth $7.52M.

More recent ABIOMED, Inc. (NASDAQ:ABMD) news were published by: Benzinga.com which released: “Abiomed Earnings Outlook” on May 02, 2018. Also Seekingalpha.com published the news titled: “ABIOMED (ABMD) Q4 2018 Results – Earnings Call Transcript” on May 03, 2018. Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway” with publication date: May 15, 2018 was also an interesting one.

More important recent salesforce.com, inc. (NYSE:CRM) news were published by: Investorplace.com which released: “Trade of the Day: Salesforce.com (CRM)” on May 03, 2018, also Fool.com published article titled: “Salesforce.com Won’t Be Running Out of Steam Anytime Soon”, Forbes.com published: “What To Watch For In Salesforce’s Q1 Earnings” on May 16, 2018. More interesting news about salesforce.com, inc. (NYSE:CRM) was released by: Prnewswire.com and their article: “Salesforce to Join Global Leaders in Paris for Inaugural Tech For Good Summit, Hosted by President of France …” with publication date: May 21, 2018.

Since December 11, 2017, it had 4 buys, and 170 insider sales for $130.43 million activity. 5,000 shares were sold by Benioff Marc, worth $566,675 on Thursday, February 1. 1,015 shares were sold by Dayon Alexandre, worth $115,177. Weaver Amy E had sold 1,400 shares worth $169,260 on Thursday, March 1. $14,629 worth of stock was sold by Roos John Victor on Thursday, March 1. $30,208 worth of salesforce.com, inc. (NYSE:CRM) was sold by Conway Craig. Shares for $1.27 million were sold by BLOCK KEITH on Tuesday, May 15.

Analysts await salesforce.com, inc. (NYSE:CRM) to report earnings on May, 29 after the close. They expect $0.18 earnings per share, up 200.00% or $0.12 from last year’s $0.06 per share. CRM’s profit will be $133.72M for 174.22 P/E if the $0.18 EPS becomes a reality. After $0.15 actual earnings per share reported by salesforce.com, inc. for the previous quarter, Wall Street now forecasts 20.00% EPS growth.

State Treasurer State Of Michigan, which manages about $12.68B US Long portfolio, upped its stake in First Horizon Natl Corp (NYSE:FHN) by 28,600 shares to 116,683 shares, valued at $2.33M in 2017Q4, according to the filing. It also increased its holding in Gilead Sciences Inc (NASDAQ:GILD) by 653,000 shares in the quarter, for a total of 2.71 million shares, and has risen its stake in Eqt Corp (NYSE:EQT).

Investors sentiment decreased to 1.19 in Q4 2017. Its down 0.15, from 1.34 in 2017Q3. It worsened, as 39 investors sold CRM shares while 274 reduced holdings. 110 funds opened positions while 261 raised stakes. 608.21 million shares or 0.25% less from 609.74 million shares in 2017Q3 were reported. Oakmont Ptnrs Limited Liability Com invested in 0.99% or 18,317 shares. Pdts Ptnrs Limited Liability Co reported 92,600 shares. The Massachusetts-based Baystate Wealth Management Limited Co has invested 0% in salesforce.com, inc. (NYSE:CRM). Ubs Asset Americas reported 3.29 million shares. Glaxis Cap Lc holds 2.14% or 15,000 shares in its portfolio. Cornerstone Advisors invested in 0.27% or 23,000 shares. Point72 Asset Ltd Partnership owns 888,585 shares. 13,386 are held by Ls Invest Advsrs Ltd Liability Company. Synovus Fincl Corporation accumulated 0.04% or 23,249 shares. Tiaa Cref Limited Liability Corp stated it has 9.87M shares or 0.66% of all its holdings. First Manhattan, a New York-based fund reported 8,321 shares. Goodman Corp holds 358 shares or 0.02% of its portfolio. Eqis Mngmt Inc stated it has 2,852 shares. Moon Capital Mngmt Lc owns 2,000 shares. Crossvault Capital Mgmt Limited Com accumulated 20,865 shares.

ABIOMED, Inc. (NASDAQ:ABMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Stephen Andrade

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts